Chemoinformaics analysis of 5,8,11,14-Eicosatetraenoic acid, methyl ester, (all-Z)-
Molecular Weight | 318.501 | nRot | 14 |
Heavy Atom Molecular Weight | 284.229 | nRig | 5 |
Exact Molecular Weight | 318.256 | nRing | 0 |
Solubility: LogS | -3.043 | nHRing | 0 |
Solubility: LogP | 3.107 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 57 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 59.345 |
nHD | 0 | BPOL | 36.713 |
QED | 0.213 |
Synth | 2.772 |
Natural Product Likeliness | 0.92 |
NR-PPAR-gamma | 0.668 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0 |
HIA | 0.037 |
CACO-2 | -4.94 |
MDCK | 0.000138531 |
BBB | 0.104 |
PPB | 0.987636 |
VDSS | 2.679 |
FU | 0.0141248 |
CYP1A2-inh | 0.685 |
CYP1A2-sub | 0.894 |
CYP2c19-inh | 0.582 |
CYP2c19-sub | 0.555 |
CYP2c9-inh | 0.635 |
CYP2c9-sub | 0.954 |
CYP2d6-inh | 0.789 |
CYP2d6-sub | 0.943 |
CYP3a4-inh | 0.916 |
CYP3a4-sub | 0.154 |
CL | 4.033 |
T12 | 0.929 |
hERG | 0.118 |
Ames | 0.958 |
ROA | 0.004 |
SkinSen | 0.965 |
Carcinogencity | 0.795 |
EI | 0.099 |
Respiratory | 0.818 |
NR-Aromatase | 0.104 |
Antiviral | No |
Prediction | 0.574194 |